What is going on in the BCRF?
Dr. Kipps Live Talk June 25th!
Dr. Kipps, the inventor of Memgen's ISF35, will present an update on CLL therapy on Wed., June 25, 2008. Register now for a free telephone education program. This program will feature Thomas J. Kipps, M.D., PhD, professor, Department of Medicine, Deputy Director of Research, Moores University of California, San Diego (UCSD) Cancer Center, San Diego, CA. Participants will have the opportunity to ask the presenter questions during the program. For more information please click the link below:
Leukemia & Lymphoma Society Program Details
(Pictured L to R: Dr. Kanti Rai and Dr. Thomas Kipps)
How to Activate YOUR Immune System: Gene Therapy Research (Part 2)
To deliver the ISF35 molecule to target malignant B lymphocytes, we use a replication defective type 5 adenovirus. The adenovirus infects the leukemic cells, resulting in the stable expression of the ISF35 molecule on the cell surface. The adenoviral proteins trigger the immune system to attack infected malignant cells, and ISF35 augments this response, resulting in a localized full-force reaction against the treated cells
(Continued) MORE INFORMATION
Fellowship Researchers at the BCRF
Current Researchers:
Emanuela Ghia, Ph.D. - University La Sapienza of Rome
Arrived on
August 2005
Yoshinori Nonomura, M.D., Ph.D.-Tokyo Medical and Dental University:
Arrived on
April 1st 2008!
Jessie-Farah Fecteau, Ph.D.-Universite Laval-Quebec, Canada:
Arrives July 7th 2008.
Christoph Steininger, M.D.-Medical University of Vienna:
Arrives August 1st 2008.
